Roche CEO comes out against approving takeover of drug manufacturer Catalent

Catalent

23/10/2024 08:28

FRANKFURT, Oct 23 (Reuters) - The CEO of Swiss
pharmaceuticals giant Roche  ROG.S  said competition authorities
should not allow the controlling shareholder of Novo Nordisk
 NOVOb.CO  to acquiring contract drug manufacturer Catalent
 CTLT.N .
     "It's not a problem for us, but it could be a problem for
other smaller players, if there is a restriction in how many
(contract manufacturers) are available. From an industry
perspective, it would be a wrong decision by authorities,"
Roche's CEO Thomas Schinecker said in a media call after the
release of quarterly sales.

 (Reporting by Ludwig Burger, Editing by Rachel More)
 ((ludwig.burger@thomsonreuters.com; +49 30 220133634;))